title: Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
authors.forename: Ying-Ching
authors.initials: YC
authors.lastname: Lai
authors.forename: Chi-Chiang
authors.initials: CC
authors.lastname: Chiou
authors.forename: Chun-Hsin
authors.initials: CH
authors.lastname: Chen
authors.forename: Ming-Chyi
authors.initials: MC
authors.lastname: Huang
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004412:Dysmenorrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011388:Prolactin / Q000097:blood / Q000187:drug effects*; D011569:Psychiatric Status Rating Scales; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D012737:Sex Factors
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D011388:Prolactin; D018967:Risperidone